Risk of hepatocellular carcinoma and secondary structure of hepatitis C virus (HCV) NS3 protein amino-terminus, in patients infected with HCV subtype 1b
- PMID: 17763321
- DOI: 10.1086/521309
Risk of hepatocellular carcinoma and secondary structure of hepatitis C virus (HCV) NS3 protein amino-terminus, in patients infected with HCV subtype 1b
Abstract
We conducted a retrospective study of 65 patients with chronic hepatitis C, to determine whether the secondary structure of the amino-terminal 120 residues of the hepatitis C virus (HCV) NS3 protein is associated with an increased risk of development of hepatocellular carcinoma (HCC). The cumulative incidence of HCC was highest among patients infected with group B HCV-1b, wherein the risk of HCC significantly increased compared with that among patients infected with group A (hazard ratio, 4.95 [95% CI, 1.43-17.11]) after adjustment for age and histological stage. This HCV-1b grouping may be a useful marker for detecting the risk of development of HCC.
Similar articles
-
Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis.Cancer. 2000 Jul 1;89(1):53-9. Cancer. 2000. PMID: 10897000
-
8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.J Gastroenterol Hepatol. 2008 Sep;23(9):1431-6. doi: 10.1111/j.1440-1746.2008.05502.x. J Gastroenterol Hepatol. 2008. PMID: 18854000
-
Evaluation of the inhibitory effect of antisense oligodeoxynucleotides on the growth of hepatitis C-associated hepatocellular carcinoma cells in vitro.Chin J Dig Dis. 2005;6(3):142-8. doi: 10.1111/j.1443-9573.2005.00207.x. Chin J Dig Dis. 2005. PMID: 16045605
-
Viral hepatitis and liver cancer: the case of hepatitis C.Oncogene. 2006 Jun 26;25(27):3834-47. doi: 10.1038/sj.onc.1209562. Oncogene. 2006. PMID: 16799625 Review.
-
Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways.J Gastroenterol Hepatol. 2007 Jun;22 Suppl 1:S108-11. doi: 10.1111/j.1440-1746.2006.04669.x. J Gastroenterol Hepatol. 2007. PMID: 17567457 Review.
Cited by
-
The impact of antiviral therapy and the influence of metabolic cofactors on the outcome of chronic HCV infection.Int J Hepatol. 2011;2011:314301. doi: 10.4061/2011/314301. Epub 2011 Nov 15. Int J Hepatol. 2011. PMID: 22164334 Free PMC article.
-
From viruses to cancer: exploring the role of the hepatitis C virus NS3 protein in carcinogenesis.Infect Agent Cancer. 2024 Aug 27;19(1):40. doi: 10.1186/s13027-024-00606-2. Infect Agent Cancer. 2024. PMID: 39192306 Free PMC article. Review.
-
Hepatitis viruses exploitation of host DNA methyltransferases functions.Clin Exp Med. 2016 Aug;16(3):265-72. doi: 10.1007/s10238-015-0372-3. Epub 2015 Jul 7. Clin Exp Med. 2016. PMID: 26148656 Review.
-
Hepatitis C virus NS5A protein down-regulates the expression of spindle gene Aspm through PKR-p38 signaling pathway.J Biol Chem. 2008 Oct 24;283(43):29396-404. doi: 10.1074/jbc.M802821200. Epub 2008 Aug 26. J Biol Chem. 2008. PMID: 18728014 Free PMC article.
-
Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus.Hepat Med. 2011 Mar 30;3:21-8. doi: 10.2147/HMER.S16991. Hepat Med. 2011. PMID: 24367218 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical